WELCOME TO GROUP OTONKOSKI’S PAGES

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate a Core Facility service, the Biomedicum Stem Cell Centre (BSCC).
Read more

Research highlights

@OtonkoskiL

Celebrating the well-reserved Albert Renold prize of @OtonkoskiT in #EASD2019 at Barcelona https://t.co/ZRL4Mw9MMm

A history lesson from @OtonkoskiT for his Albert Renold Prize Lecture. Strap in, he wrote the book! #EASD2019twitter.com/i/web/status/1…